ClinicalTrials.govpublic full text
Polatuzumab Vedotin, Rituximab, Ifosfamide, Carboplatin, and Etoposide (PolaR-ICE) as Initial Salvage Therapy for the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma
diffuse large b-cell lymphoma unclassifiable, recurrent diffuse large b-cell lymphoma, recurrent primary mediastinal (thymic) large b-cell cell lymphoma, recurrent transformed b-cell non-hodgkin lymphoma, refractory diffuse large b-cell lymphoma, refractory primary mediastinal (thymic) large b-cell cell lymphoma, refractory transformed b-cell non-hodgkin lymphoma, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 837373
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.